ImmunoBreast - A Phase Ib Study
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Breast Cancer|Metastatic Breast Cancer
Interventions: OTHER: ALECSAT
Sponsor: Henrik Ditzel
Collaborators: CytoVac A/S|National Board of Health, Denmark